Patents for A61P 13 - Drugs for disorders of the urinary system (56,135)
02/1998
02/10/1998US5716959 Administering substituted piperazines having hydroxy- or amino-alkyl groups on one nitrogen and carboxylic, phosphoric or sulfonic alkyl groups on the other nitrogen, for treatment of cancer and autoimmune diseases
02/10/1998US5716955 Cytokine inhibitor
02/10/1998US5716777 Regulation of meiosis using sterols
02/06/1998CA2212204A1 8-substituted b-nor-6-thiaequilenin compounds having activity as selective estrogen receptor modulators
02/05/1998WO1998004727A1 Recombinant pox virus for immunization against tumor-associated antigens
02/05/1998WO1998004517A1 Arylcycloalkane carboxylic esters, their use, pharmaceutical compositions and preparation
02/05/1998WO1998004256A1 Amino acid compositions and use thereof in immunosuppression
02/05/1998WO1997033912A3 Uses of gdnf and gdnf receptor
02/05/1998CA2261692A1 Arylcycloalkane carboxylic esters, their use, pharmaceutical compositions and preparation
02/05/1998CA2260956A1 Amino acid compositions and use thereof in immunosuppression
02/04/1998EP0822185A1 B-3-adrenergic agonists as antidiabetic and antiobesity agents
02/04/1998EP0821960A1 Use of xanthine derivatives for the modulation of apoptosis
02/04/1998EP0821952A1 Use of isoxazole and crotonic acid amide derivatives for the modulation of apoptosis
02/04/1998EP0821585A1 USE OF $g(a) 1L? AGONISTS IN THE TREATMENT OF INCONTINENCE
02/04/1998CN1172483A Substituted heterocyclic compounds, preparation method thereof and pharmaceutical compositions containing same
02/03/1998US5714508 Inhibitors of angiotensin ii
02/03/1998US5714486 Methods for using (2-imidazolin-2-ylamino) quinoxaline derivatives
02/03/1998US5714473 Chemotherapy; mixture with alkali metal citrate
02/03/1998US5714381 DNA encoding human alpha 1 adrenergic receptors and uses thereof
02/03/1998CA1339660C Derivatives of cyclohexane
01/1998
01/31/1998CA2211866A1 .beta.-adrenergic agonists
01/29/1998WO1998003539A1 G-protein coupled receptor hnfds78
01/29/1998WO1998003511A1 New triazolopurines, method of preparing them and their use as drugs
01/29/1998WO1998003507A1 Pyrazolopyridine compound and pharmaceutical use thereof
01/29/1998WO1998003484A1 Substituted pyridines as selective cyclooxygenase-2 inhibitors
01/29/1998WO1998003189A1 Use of conantokins
01/29/1998WO1998003067A1 S(-)-tolterodine in the treatment of urinary and gastrointestinal disorders
01/29/1998DE19629378A1 Neue Triazolopurine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel Triazolopurine new, processes for their preparation and their use as medicaments
01/29/1998CA2261570A1 Use of conantokins
01/29/1998CA2260990A1 Pyrazolopyridine compound and pharmaceutical use thereof
01/29/1998CA2256736A1 New triazolopurines, method of preparing them and their use as drugs
01/28/1998EP0820991A2 Cycloalkyl derivatives as bone resorption inhibitors and vitronectin receptor antagonists
01/28/1998EP0820988A2 Imino derivatives as bone resorption inhibitors and vitronectin receptor antagonists
01/28/1998EP0820445A1 Inhibitors of farnesyl-protein transferase
01/28/1998EP0820441A1 INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS
01/28/1998EP0820426A1 SUBSTITUTED DIBENZ[a,f]AZULENES AND METHODS OF PREPARATION
01/28/1998EP0820302A1 Combination compositions containing benazepril or benazeprilat and valsartan
01/28/1998EP0820294A1 Use of nitric oxide-releasing agents to treat impotency
01/28/1998EP0820290A1 Use of vitamin d 2 or vitamin d 4-derivatives for the manufacture of a medicament for the treatment of secondary hyperparathyroidism
01/28/1998EP0820288A1 Use of dextromethorphan or dextrorphan for the treatment of urinary incontinence
01/28/1998EP0641791B1 Novel benzothiophene derivative
01/28/1998CN1171743A Novel tumor suppressor gene HIC-1
01/28/1998CN1037179C 1, 4 -benzoxazino derivatives
01/28/1998CN1037176C Benzenealkanoic acids for cardiovascular diseases
01/27/1998US5712296 Substituted pyridines and 2-oxo-1,2-dihydropyridines
01/27/1998US5712294 Antiinflammatory agents
01/27/1998US5712287 Method of treating urinary bladder dysfunctions
01/27/1998US5712271 Method of treating urinary bladder dysfunctions
01/27/1998US5712122 Carboxy terminal peptide-extended proteins
01/24/1998CA2211148A1 Novel imino derivatives as inhibitors of bone resorption and vitronectin receptor antagonists
01/22/1998WO1998002436A1 Thiadioxobenzodiazepine inhibitors of farnesyl protein transferase
01/22/1998WO1997035591A3 Method of treating ciliary dyskinesia with uridine triphosphates and related compounds
01/22/1998CA2260216A1 Thiadioxobenzodiazepine inhibitors of farnesyl protein transferase
01/21/1998EP0819125A1 Thienyl-, furyl-, pyrrolyl- and biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin
01/21/1998EP0819009A1 Ovulation triggering drugs
01/21/1998EP0819001A1 Use of substituted piperidine or pyrrolidine compounds for treating sigma-receptor modulated disorders
01/21/1998EP0625977B1 Piperazine derivatives as 5-ht1a antagonists
01/21/1998CN1171119A Binding agents for curing inflammatory, autoimmune or allergic diseases
01/21/1998CN1171113A Mutants of Rb and p53 genes and uses thereof
01/21/1998CN1171109A Novel quinuclidine derivatives and medicinal composition thereof
01/21/1998CN1171051A Compounds with progesterone-antagonistic and anti-oestrogen properties intended for combined use in female contraception
01/21/1998CN1170719A Estrogenic agents
01/20/1998US5710275 7β-substituted-4-aza-5α-androstan-3-ones as 5α-reductase inhibitors
01/20/1998US5710247 Process and intermediates for the synthesis of LHRH antagonists
01/20/1998US5710171 Anticancer and antitumor agents
01/20/1998US5710169 Therapeutic heterocycles
01/20/1998US5710163 Benzo f!quinolinones
01/20/1998US5710151 Method of treating urinary bladder dysfunctions
01/20/1998US5710149 Piperazine derivatives as 5-ht antagonists
01/20/1998US5710139 Heterocyclic compounds
01/20/1998US5710022 Nuclear mitotic phosphoprotein
01/20/1998US5709860 Induction of cytotoxic T-lymphocyte responses
01/20/1998CA2059000C Fused-ring aryl substituted imidazoles
01/15/1998WO1998001145A1 Therapeutic applications of t-bam (cd40l) technology to treat diseases involving smooth muscle cells
01/15/1998WO1998001143A1 Use of artichoke (cynara) extracts
01/14/1998EP0818453A1 Benzothiophene compounds and methods of use
01/14/1998EP0817861A1 Gene transfer into the kidney
01/14/1998EP0817800A1 Human g-protein coupled receptors
01/14/1998EP0817775A1 Quinazoline derivatives
01/14/1998EP0817645A1 Method for treatment of benign prostatic hypertrophy
01/14/1998EP0817628A2 Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules
01/14/1998EP0662950B1 Benzenealkanoic acids for cardiovascular diseases
01/13/1998US5708034 Substituted sulfonimidamides, processes for their preparation, their use as a medicament or diagnostic, and medicament comprising them
01/13/1998US5708023 Nonirritating gel for skin
01/13/1998US5708020 Arylalkyl(thio)amides
01/13/1998US5708016 Pseudopeptides derived from neurokinins
01/13/1998US5708010 Methods of inhibiting myeloperoxidase activity
01/13/1998US5708009 Methods of inhibiting myeloperoxidase activity
01/13/1998US5707999 Urogenital disorders
01/13/1998US5707980 Administering 1a,25-dihydroxyvitamin d4 to patient
01/13/1998US5707826 Transpeptidation, replacing terminal portion of peptide sequence with another sequence, forming amide at c-terminal position in one step
01/10/1998CA2206997A1 Benzothiophene compounds and methods of use
01/08/1998WO1998000543A1 Hepatocyte growth factor receptor agonists and uses thereof
01/08/1998WO1998000411A1 Prenyl transferase inhibitors
01/08/1998WO1998000390A1 Smooth muscle spasmolytic agents, compositions and methods of use thereof
01/08/1998WO1998000152A1 Non-aqueous protic peptide formulations
01/08/1998WO1998000135A1 Treatment of sepsis-induced acute renal failure and renal vasoconstriction and catecholamine-induced renal and mesenteric vasoconstriction
01/08/1998WO1998000126A1 Treating urinary incontinence using (s)-oxybutynin and (s)-desethyloxybutynin
01/08/1998DE19627376A1 Verwendung von Artischocken-(Cynara)-Extrakten Use of artichoke (Cynara) extracts
01/08/1998CA2259403A1 Non-aqueous protic peptide formulations